GRP and pachyonychia congenita: With the aim to develop a personalized management of PC patients, several ligands of GRPR, such as radiolabeled bombesin analogs (ClinicalTrials.gov Identifiers: NCT02440308 and NCT03724253) [72] able to guide the diagnosis, as well as treatment of PC, are being tested in clinical trials.